Metabolic kinetics of 5-hydroxytryptamine and the research targets of functional gastrointestinal disorders.
about
Mindfulness-based therapies in the treatment of functional gastrointestinal disorders: a meta-analysis.Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial.Novel investigational drugs for constipation-predominant irritable bowel syndrome: a review.5-HT3 receptors: A potential therapeutic target for epilepsy.Potential rat model of anxiety-like gastric hypersensitivity induced by sequential stress.
P2860
Metabolic kinetics of 5-hydroxytryptamine and the research targets of functional gastrointestinal disorders.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Metabolic kinetics of 5-hydrox ...... al gastrointestinal disorders.
@en
type
label
Metabolic kinetics of 5-hydrox ...... al gastrointestinal disorders.
@en
prefLabel
Metabolic kinetics of 5-hydrox ...... al gastrointestinal disorders.
@en
P2860
P1476
Metabolic kinetics of 5-hydrox ...... al gastrointestinal disorders.
@en
P2093
Fuchun Jing
P2860
P2888
P304
P356
10.1007/S10620-014-3244-X
P577
2014-06-12T00:00:00Z
P6179
1040892029